Letter to the Editors: Re: Noninvasive Tests in Advanced Fibrosis Due to NASH: Critical Insights From STELLAR Trials.
The recently published article by Anstee et al. provides key insights into the complex etiopathogenesis of nonalcoholic steatohepatitis (NASH)-mediated advanced fibrosis.(1,2) STELLAR-trials baseline data strongly emphasized predictive-value(s)/reliability of non-invasive tests (NITs) for bias-free, accurate assessment of liver-fibrosis, thereby warranting future public health research for significantly diminishing the increasing burden of hepatic malignancies in susceptible populations worldwide. This article is protected by copyright. All rights reserved.